Antibodies to IL-6 and their uses
View Patent ↗Antibodies and antigen-binding portions thereof that bind to human IL-6 are provided. Also provided are nucleic acids encoding such antibodies and antigen binding portions, methods of making such antibodies and antigen binding portions, compositions comprising such antibodies or antigen binding portions, and uses of such antibodies or antigen binding portions.
1. An isolated human monoclonal antibody or antigen-binding portion thereof comprising a heavy chain variable (V H ) domain amino acid sequence comprising
the V H CDR1 as set forth in SEQ ID NO:5, the V H CDR2 as set forth in SEQ ID NO:6, and the V H CDR3 as set forth in SEQ ID NO:7, and comprising a light chain variable (V L ) domain amino acid sequence comprising the V L CDR1 as set forth in SEQ ID NO:16, the V L CDR2 as set forth in SEQ ID NO:17, and the V L CDR3 as set forth in SEQ ID NO:18;
wherein said antibody binds specifically to human IL-6.
2. An isolated human monoclonal antibody or antigen-binding portion thereof comprising the heavy chain variable (V H ) domain amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:29, and SEQ ID NO:37, and further comprising the light chain variable (V L ) domain amino acid sequence as set forth in SEQ ID NO:15; wherein said antibody binds specifically to human IL-6.
3. An isolated human monoclonal antibody or antigen-binding portion thereof comprising V L and V H domains selected from the group consisting of:
the V L domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8014; and the V H domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8013;
the V L domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8016; and the V H domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8015; and
the V L domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8014; and the V H domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8019;
wherein said antibody binds specifically to human IL-6.
4. An isolated human monoclonal antibody or antigen-binding portion thereof comprising the heavy chain CDR1, CDR2 and CDR3 of the V H domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8015; and the light chain CDR1, CDR2 and CDR3 of the V L domain encoded by the cDNA insert of the plasmid deposited with the ATCC under accession number PTA-8016;
wherein said antibody binds specifically to human IL-6.
5. An isolated human monoclonal antibody or antigen binding portion thereof comprising a heavy chain and a light chain selected from the group consisting of:
a) the heavy chain having the amino acid sequence of SEQ ID NO:3 and the light chain having the amino acid sequence of SEQ ID NO:14;
b) the heavy chain having the amino acid sequence of SEQ ID NO:24 and the light chain having the amino acid sequence of SEQ ID NO:26;
c) the heavy chain having the amino acid sequence of SEQ ID NO:28 and the light chain having the amino acid sequence of SEQ ID NO:26; and
d) the heavy chain having the amino acid sequence of SEQ ID NO:32 and the light chain having the amino acid sequence of SEQ ID NO: 14.
6. The isolated human monoclonal antibody or antigen binding portion thereof according to claim 5 wherein the heavy chain amino acid sequence is SEQ ID NO:28 and the light chain amino acid sequence is SEQ ID NO:26.
7. The isolated monoclonal antibody or an antigen-binding portion thereof according to claim 1 , further comprising V H FR1, FR2, FR3 and FR4 and V L FR1, FR2, FR3 and FR4 amino acid sequence of an antibody encoded by the cDNA insert of the plasmid deposited with the ATCC under the accession number selected from the group consisting of: PTA-8013, PTA-8014, PTA-8015, PTA-8016, PTA-8018, and PTA-8019.
8. A composition comprising the antibody or antigen-binding portion according to claim 1 and a pharmaceutically acceptable carrier.
9. An isolated human monoclonal antibody or antigen-binding portion thereof comprising the heavy chain variable (V H ) domain amino acid sequence as set forth in SEQ ID NO:29 and the light chain variable (V L ) domain amino acid sequence as set forth in SEQ ID NO:15.
10. An isolated human monoclonal antibody or antigen binding portion thereof comprising the heavy chain amino acid sequence as set forth in SEQ ID NO:28 and the light chain amino acid sequence as set forth in SEQ ID NO:26.